CN112195286B - Probe for detecting human papilloma virus HPV26 and kit thereof - Google Patents

Probe for detecting human papilloma virus HPV26 and kit thereof Download PDF

Info

Publication number
CN112195286B
CN112195286B CN202011260516.1A CN202011260516A CN112195286B CN 112195286 B CN112195286 B CN 112195286B CN 202011260516 A CN202011260516 A CN 202011260516A CN 112195286 B CN112195286 B CN 112195286B
Authority
CN
China
Prior art keywords
hpv
kit
probe
library
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011260516.1A
Other languages
Chinese (zh)
Other versions
CN112195286A (en
Inventor
陈世民
杨帆
黄晓园
何良
刘佳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Kaideweisi Biotechnology Co ltd
Original Assignee
Wuhan Kaideweisi Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Kaideweisi Biotechnology Co ltd filed Critical Wuhan Kaideweisi Biotechnology Co ltd
Priority to CN202011260516.1A priority Critical patent/CN112195286B/en
Publication of CN112195286A publication Critical patent/CN112195286A/en
Application granted granted Critical
Publication of CN112195286B publication Critical patent/CN112195286B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/708Specific hybridization probes for papilloma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a probe for detecting human papillomavirus HPV26 and a kit thereof, wherein the probe group comprises probes capable of specifically capturing HPV26 genome; the invention has comprehensive detection range, greatly improved detection efficiency and accurate result.

Description

Probe for detecting human papilloma virus HPV26 and kit thereof
Technical field:
The invention relates to a probe and a kit thereof, in particular to a probe and a kit for capturing and sequencing human papillomavirus HPV26 genes.
The background technology is as follows:
Cervical cancer refers to a malignancy occurring in the cervical vagina and cervix, one of the most common gynaecological malignancies, next to breast cancer. Cervical cancer is the second leading cancer incidence and the third leading mortality in women aged 15-44 in China. Numerous studies have demonstrated that cervical cancer is predominantly caused by persistent infection with high-risk human papillomaviruses (Human Papillomavirus, HPV) and that the presence of high-risk HPV DNA is detected in 99.7% of cervical cancer patients. Currently, more than 200 HPV genotypes have been identified, about 40 being associated with genital tract infections. HPV is classified into high-risk type and low-risk type according to the level of risk of cervical cancer, wherein 13 genotypes including HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and the like are classified into high-risk type, and 5 genotypes including HPV 26, 53, 66, 73, 82 and the like are classified into medium-risk type. These 18 types of HPV are mainly associated with cervical intraepithelial neoplasia, cinii, iii grade and cervical cancer. The low risk is generally unrelated to malignant lesions, mainly causing condyloma acuminatum and low grade CIN (CINI). Therefore, by detecting whether high-risk HPV infection exists in cervical exfoliated cells and periodically detecting whether HPV virus in cervical exfoliated cells is continuously infected or not, the detection method is particularly important in early screening, auxiliary diagnosis, post-healing evaluation and other links of cervical cancer.
In general, HPV is present in a free state after infection of host cells, and its DNA is still free in the cytoplasm of the host cells, and as the host cells divide and replicate, HPV DNA is inserted into the human genome, a process also known as HPV integration. Once HPV DNA is accidentally integrated into the host cell chromosome, viral proteins will replicate in disorder, and host cell genetic material structure and associated gene expression changes, resulting in uncontrolled division of the host cell, thereby inducing canceration. Although HPV DNA is detected in 99.7% or more of cervical cancers, cervical cancer does not occur in every patient infected with high-risk HPV. With the progress of molecular biology and cytogenetics, the integration of HPV with host chromosomes is an important step in cervical cell immortalization, an important marker that leads to cervical intraepithelial neoplasia to cervical cancer malignancy. Integration of HPV with the host cell chromosome, which is the most important risk factor for cervical cancer development, is found in more than 90% of cervical cancer tissues. Low-risk HPV rarely causes cervical cancer, irrespective of viral load in the host, because it rarely undergoes viral integration. The integration rates of high-risk HPV in HSIL and squamous cell carcinoma were 76.2% and 88.2%, respectively, with only 37% in LSIL. HPV exists in a non-free state in invasive cervical cancer (about 60.9%) 20% higher than carcinoma in situ. Approximately 90% of HPV 16-positive cervical cancer cases are integrated, with only 16% of cases in pure free form. It is indicated that the incidence of viral integration is positively correlated with the incidence of cervical cancer, and the status of viral integration is positively correlated with the extent of cervical cancer. HPV DNA and human genome integration are used as markers of cervical lesion degree, and have very important significance for early diagnosis of cervical cancer.
The early symptoms of cervical cancer are not obvious, and the death rate caused by cervical cancer can be effectively reduced only by early screening and early warning of cervical cancer. Traditional pathological detection means, such as cervical smear detection, are easily affected by factors such as sampling, staining, subjective judgment of cytopathologists and the like, so that the application of cytopathologists to detect HPV has the defects of low sensitivity, poor specificity, high false negative rate and false positive rate, incapability of typing HPV and the like. The current real-time fluorescent Polymerase Chain Reaction (PCR) method commonly used in clinic has low detection flux, is difficult to meet the requirement of simultaneously detecting a plurality of types of HPV clinically when detecting different types of HPV respectively, and is not suitable for large-scale screening of cervical cancer. More importantly, the methods used at present can only judge whether HPV infection and HPV infection type exist or not, and cannot judge whether HPV DNA is integrated with human genome or not, and HPV integration event is an important factor for cervical cancer. The high-throughput sequencing technology (next-generation sequencing technology) has the advantages of accuracy, high sensitivity, rapidness and low cost, and can sequence a plurality of genes at the same time, so that the method can realize HPV typing detection and HPV integration detection. The liquid phase hybridization gene capturing technology can enrich relevant gene fragments of a target region, and can greatly reduce the cost of human gene sequencing, genetic research and gene diagnosis by combining a new generation gene sequencing technology, improve the sequencing depth and more accurately discover the mutation information of a specific region. The design of the capture probe is the core of the liquid phase hybridization capture technology. In summary, the probe set and the kit for detecting HPV typing and integration provided by the invention can accurately type 18 high-risk HPVs at one time and determine the integration condition of the HPVs in human genome, have the advantages of processing a plurality of samples at one time, being high in sensitivity and specificity, and have great clinical significance.
The invention comprises the following steps:
The present invention aims to solve the above-mentioned shortcomings of the prior art and provide a capture probe set for detecting HPV and a kit thereof; according to the 18 HPV whole genome sequences, the invention designs a synthetic probe sequence, and specifically captures, amplifies and sequences target fragments so as to achieve the purpose of detecting samples. The probe set comprises probes capable of specifically capturing all 18 HPV genomes. 18 HPV types and 5 HPV integration conditions can be comprehensively, rapidly and accurately detected, wherein the 18 HPV types are HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82 respectively; the 5 HPVs integrate as HPV16, 18, 33, 52, 58 respectively.
The invention adopts the following technical scheme:
the invention provides a probe for detecting HPV26 typing and integration of human papillomavirus, and the information of the probe is shown in Table 1
The invention also provides a kit for detecting HPV26 typing and integration of human papillomavirus. The kit comprises the probe for detecting human papillomavirus HPV26 typing and integration; preferably, the kit further comprises a library buffer 1, a library buffer 2, an enzyme 1, an enzyme 2, a linker, a PCR amplification primer 1, a PCR amplification primer 2, a PCR reaction mixture, a blocking sequence 1, a blocking sequence 2, a blocking reagent, a hybridization buffer, a PCR amplification primer 3, a PCR amplification reaction solution, a positive control, a negative control, a capture buffer, a cleaning buffer 1, a cleaning buffer 2 and a capture magnetic bead; preferably, the blocking sequence 1 is Cot-1 DNA and the blocking sequence 2 is a double-stranded oligonucleotide.
Further, the components of the kit are shown in Table 2.
The invention also discloses a method for using the probe for detecting human papillomavirus HPV26 typing and integration and a kit thereof, which mainly comprises the following steps:
(1) Design of Capture probes for HPV26
(2) Sample DNA extraction, fragmentation and construction of DNA library
(3) Library target region targeted capture and quantification
(4) High throughput sequencing
(5) Bioinformatic analysis of gene sequences
The invention provides a method for capturing HPV genes, which specifically comprises the following steps: extracting whole genome DNA of cervical exfoliated cells, randomly breaking the whole genome DNA into fragments with the size of 200-300bp, and constructing a DNA library by using partial fragments containing the sequence of HPV genes; the HPV probes (carrying biotin marks and capable of being combined by hybridization with HPVDNA sequences) related by the invention are hybridized with the constructed pre-library, and sequences containing HPV genes can be hybridized specifically by combining biotin on the probes with magnetic beads; washing and removing the sequence without HPV, thereby enriching HPV gene fragments, and capturing HPV sequences by the kit; HPV genotype of the sample to be tested and whether integration with human genome occurs can be obtained by sequencing through high throughput of a sequencer Nextseq CN500,500 and analyzing HPV information in the sequencing result.
The invention has the following beneficial effects:
(1) The invention designs the probe capable of rapidly and accurately capturing the complete sequence of HPV26 genome, and can effectively improve the detection specificity. The traditional methods such as fluorescent quantitative PCR only aim at a certain section of the HPV sequence, and the detection range of the probe can cover the whole length of the HPV genome.
(2) The invention uses HPV probes to sequence library samples captured with target areas by using a high-throughput sequencing technology. The HPV sequence is targeted, enriched and captured by using the HPV probe, and then high-throughput sequencing is carried out, so that the detection sensitivity is high.
(3) According to the invention, a plurality of samples can be processed at one time, different Barcode is added into a plurality of different samples to distinguish, and then the samples are mixed for on-machine sequencing, so that the detection flux can be effectively improved.
Description of the drawings:
FIG. 1 shows the parameters of a PCR instrument for end repair, 3' end addition "A" reaction;
FIG. 2 shows the parameters of the Pre-PCR procedure.
The specific embodiment is as follows:
The invention is further illustrated by the following examples. Unless otherwise indicated, all reagents commonly used in the art for use in the present invention are commercially available.
Example 1: design and preparation of the Probe set of the invention
According to the base complementary pairing principle, oligonucleotide probes complementary to the DNA sequence of HPV26 are designed. Because of the complex structure of the genome sequence, irregular regions such as high GC, high AT regions and the like exist, and meanwhile, because of the limitation of the second generation sequencing read length, the design of the probe becomes particularly critical, and a plurality of factors such as coverage rate, uniformity, capture efficiency and the like need to be comprehensively balanced. The specific principle of probe design is as follows:
(1) Length: the selectable interval is 80-150bp, and 100bp is generally selected.
(2) Number of probe layers: i.e. how many probes are covered on average over the target area, 3 layers are generally recommended and a shingled design is required.
(3) Specificity: i.e., the uniqueness of the probe in the genomic range, the higher the specificity, the higher the capture efficiency of the probe. Designing probes in low complexity areas should be avoided; but in special cases, such as where some hotspots are located exactly in low complexity areas, then it is necessary to comprehensively evaluate the sequence of that area as well as adjacent areas and carefully place the probes.
(4) Binding ability: the GC content is about 50%, and the probe capturing capacity is the strongest. The high GC region has strong probe binding capacity, but the DNA fragment has stronger self-binding capacity (longer length) and larger probe competition resistance; the DNA fragment of the high AT region itself is weak in binding ability but also weak in binding ability of the probe thereto, and therefore, it is necessary to appropriately increase the number of probes in the high GC and high AT regions to compensate for the disadvantages in competitive resistance and binding ability.
Preparing a probe: the designed probes are synthesized on a chip in a large quantity by a photo-chemical synthesis method, and the biotin-labeled probes are obtained through PCR or transcription reaction.
Example 2: the kit of the invention comprises, preparation and use
The kit reagent for HPV detection described in the example.
The kit comprises the following components: the invention relates to a capture probe for detecting HPV, a library buffer solution 1, a library buffer solution 2, an enzyme 1, an enzyme 2, a connector, a PCR amplification primer 1, a PCR amplification primer 2, a PCR reaction mixture, a blocking sequence 1, a blocking sequence 2, a blocking reagent, a hybridization buffer solution, a PCR amplification primer 3, a PCR amplification reaction solution, a positive control, a negative control, a capture buffer solution, a cleaning buffer solution 1, a cleaning buffer solution 2 and a capture magnetic bead. The information of the specific composition is shown in table 2,
The using method of the kit comprises the following steps:
1. Sample library preparation
(1) Fragmenting: taking out 1000 ng DNA, thawing, shaking, mixing, adding water to 100 μl, and breaking with Biorupter Pico ultrasonic breaker. The specific parameters are set as follows: setting parameters of ON 30 seconds and OFF 30 seconds as 1 cycle after the temperature of the cold circulation instrument is reduced to 4 ℃, wherein every 10 cycles are one round, and carrying out 3 rounds in total; 1 μl of the sample was used for fragment detection using Qsep a1, and the main peak of the sample detection after normal disruption was about 150: 150 bp-200: 200 bp.
(2) End repair plus a: and (3) carrying out end repair and adding ' A ' to the 3' end of the sample obtained in the last step. The specific reaction system is as follows: 35. mu.L of DNA fragment, 5. Mu.L of ERA buffer, 10. Mu.L of end repair enzyme. After mixing, a PCR program is run, and parameters of a PCR instrument are set as shown in FIG. 1 (50 mu L system, hot cover 85 ℃);
(3) And (3) adding a joint: and (3) performing joint connection on the sample obtained in the last step. The specific reaction system is as follows: 50. mu.L of the sample from which the reaction of the previous step was completed, 5. Mu.L of the linker, 15. Mu.L of enzyme-free water, 20. Mu.L of the ligation buffer, 10. Mu.L of ligase; after mixing, the PCR instrument program (no hot lid is required) was run and PCR instrument parameters were set: closing the heat cover, cooling to 4 ℃ for 30 minutes at 20 DEG C
(4) Purifying magnetic beads: immediately after the end of the procedure, the reaction product of the previous step was purified using purification magnetic beads. The purification system is as follows: 100. mu.L of the reaction product of the previous step, 100. Mu.L of purified magnetic beads.
(5) Pre-PCR amplification reaction: the purified product of the above step is used as a template for the Pre-PCR reaction. The specific reaction system is as follows: 20. mu.L of the purified product of the previous step, 25. Mu.L of the PCR reaction mixture, 2.5. Mu.L of the PCR amplification reaction primer 1 (20. Mu.M), 2.5. Mu.L of the PCR amplification reaction primer 2 (20. Mu.M). After mixing, the sample was placed on a PCR apparatus and the PCR procedure was started as shown in FIG. 2 (50. Mu.L system, hot lid temperature 105 ℃);
note that: TPE1.0index No. 1-8 in PCR amplification primer 1 (Table 3); TPE2.0index number in PCR amplification reaction primer 2 is 1# to 12#; the index number used is recorded (table 4).
(6) Purifying magnetic beads: immediately after the end of the procedure, the reaction product of the previous step was purified using 50. Mu.L of purification beads.
2. Sample liquid phase hybridization
(1) Standing and thawing the sealing sequence 1 and the sealing sequence 2 to prepare a mixed solution 1, wherein the mixed solution specifically comprises the following components: 750ng library, 5. Mu.L blocking sequence 1, 2. Mu.L blocking sequence 2.
(2) Taking out the blocking reagent and the probe in the kit, standing, thawing, shaking, mixing, and preparing a mixed solution 2 (ice operation) according to 5 mu L of the blocking reagent and 2 mu L of the probe.
(3) And taking out the hybridization buffer solution in the kit, thawing at room temperature, taking out 20 mu L of the hybridization buffer solution after thawing, and incubating the hybridization buffer solution in a constant-temperature mixing instrument at 65 ℃ for later use.
(4) 13 Mu L of hybridization buffer solution is added into the mixed solution 2, and after being blown and mixed uniformly, the liquid is collected by short centrifugation and is placed at room temperature for standby.
(5) Using a temperature-controllable vacuum drier, setting a drying temperature at 45-50 ℃, opening a pipe cover until the volume of the mixed solution 1 is less than 10 mu L, supplementing to 10 mu L by using enzyme-free water, gently sucking and beating, uniformly mixing, centrifuging for a short time, and placing on ice for standby. The concentration time should not be too long, so that the evaporation to dryness is prevented.
(6) The concentrated mixture 2 was placed in a PCR apparatus and incubated at 95℃for 5min and at 65℃for 2min (the temperature of the hot lid was 105 ℃) and no removal was required after the incubation.
(7) The hybridization buffer-added mixture 1 was placed in a PCR apparatus and incubated at 65℃for 2min (thermal cover temperature 105 ℃).
(8) And (3) adding 20 mu L of the mixed solution 1 into the mixed solution 2, fully and uniformly mixing, hybridizing for 16-24 hours at 65 ℃, keeping the hybridized product in a PCR instrument, and entering a capturing step.
3. Capturing
(1) Taking out the magnetic beads in the kit in advance, balancing for 30min at room temperature, and shaking and mixing uniformly.
(2) The 50. Mu.L of magnetic beads were removed and placed in a fresh reaction tube, and the tube was placed on a magnetic rack for 1min until the liquid was clear, taking care to discard the liquid (note not to attract the beads).
(3) 200 Mu L of capture buffer solution is added to the magnetic beads, after blowing and mixing evenly, a centrifuge tube is placed on a magnetic rack for standing for 1min until liquid is clear, and the liquid is carefully sucked and abandoned (note that the magnetic beads are not sucked).
(4) Repeating the step (3) for three times.
(5) Re-adding 200 mu L of capture buffer solution into the magnetic beads to re-suspend the magnetic beads, adding the re-suspended magnetic beads into a hybridization product, and placing a PCR tube on a rotary mixer to combine for 30min at room temperature.
(6) Taking out the cleaning buffer solution 1 and the cleaning buffer solution 2 in the kit, standing the cleaning buffer solution 1 at room temperature for later use, and preheating the cleaning buffer solution 2 at 65 ℃ for more than 5 minutes for later use.
(7) The captured product was placed on a magnetic rack for 1min and allowed to stand for 1min until the liquid was clear, taking care to discard the liquid (note not to attract magnetic beads).
(8) The centrifuge tube was removed from the magnetic rack, 200. Mu.L of washing buffer 1 was added, and after mixing by blowing, the tube was rotated on a mixer for 15min, placed on the magnetic rack for 1min until the liquid was clear, and the liquid was carefully removed (note not to be attached to the beads).
(9) The centrifuge tube was removed from the magnetic rack, 200. Mu.L of a pre-heated washing buffer 2 at 65℃was added, and after being mixed well by blowing, the mixture was placed on a constant temperature shaker (65℃at 800 rpm) for 10 minutes, and placed on the magnetic rack for 1 minute until the liquid was clear, and the liquid was carefully sucked off (note not to suck the beads).
(10) The step (9) is repeated three times.
(11) The centrifuge tube was removed from the magnetic rack, 200. Mu.L of freshly prepared 80% ethanol was added, and the mixture was allowed to stand on the magnetic rack for 30sec until the liquid was clear, and the liquid was carefully removed (note not to the beads)
(12) The reaction tube is left on the upper magnetic frame and dried for 3-5 min at room temperature to volatilize the residual ethanol, and the surface of the magnetic beads is matt (excessive drying can lead to the reduction of DNA yield).
(13) The centrifuge tube was removed from the magnetic rack and 30 μl of enzyme-free water was added to resuspend the beads for use.
(14) A mixed solution 3 is prepared, and a 0.2mL PCR tube is used, wherein the specific reaction system is as follows: 18. Mu.LPCR amplification buffer, 1. Mu.LPCR amplification primer, 1. Mu.LPCR amplification reaction solution.
(15) 20. Mu.L of the above reaction system was added to the washed product and thoroughly mixed.
(16) PCR amplification was performed in a PCR apparatus according to the reaction procedure of Table 5.
(17) Purification after amplification, purification of the amplified product was performed using commercial nucleic acid purification magnetic beads, and specific procedures were performed as directed by the kit instructions. All purified products were pipetted onto ice and steps 2-3 were repeated and either the sequencing phase was entered or stored at-20.+ -. 5 ℃.
4. Capture library quality control
(1) The concentration of the library is determined using nucleic acid quantification kit QubitdsDNA HS ASSAY KIT and the associated instrumentation, and the library concentration should be greater than 1 ng/. Mu.L. Otherwise, the library is not satisfactory and hybridization capture should be performed again.
(2) Taking a sample library or a reference substance library, and determining the size of library fragments by using STANDARD CARTRIDGE KIT (S2) and a matched instrument, wherein the size of the library fragments is concentrated between 250bp and 500bp, and no obvious small fragment and large fragment miscellaneous peaks exist. Otherwise, the library sample does not meet the requirements, and hybridization capture should be carried out again.
5. Library qPCR quantification
The library to be enriched on-boarding is quantified using KAPA Library Quantification Kit kit to adjust to the appropriate on-boarding concentration.
(1) Reagent preparation: 1) Preparing a proper amount of DNA dilution buffer: 1XIDTE buffer was diluted to 0.1X using enzyme free water, approximately 1.2mL dilution buffer per library. The buffer was allowed to warm to room temperature before use. 2) The components in the thawing kit on ice are fully and uniformly mixed before use, and are briefly centrifuged and placed on ice for standby.
(2) Sample preparation: 1) An appropriate library dilution (using enzyme-free water) was prepared. 1. Mu.L of enrichment library was taken for 1: 100. 1: 10000. 1:20000 dilution.
(3) To each well of the PCR reaction plate to be reacted, 8. Mu.L of a mixed solution containing the primer was added, and the mixed solution was composed of: 5 mu LMaster Mix,1 mu L primer, 1.8 mu L water, 0.2 mu LLow Rox.
(4) To each sample well was added the corresponding 2. Mu.L of diluted DNA library (volume ratio 1:1000 and 1:20000).
(5) To each of the wells of the standard, 2. Mu.L of DNA standard was added in order from low concentration to high concentration.
(6) To the negative control wells, 2 μl dilution buffer was added.
(7) Sealing the PCR reaction plate, and centrifuging in a microplate centrifuge for 1min.
(8) The reaction plate was loaded onto a qPCR instrument and the qPCR instrument was run according to the parameters of table 6 below.
(9) Concentration calculations of the library to be tested were performed according to KAPA Library Quantification Kit kit instructions. If the final total molar mass of the library is less than 0.02p molar, library hybridization enrichment or library construction is needed again, and if the library is unqualified again, detection is stopped.
6. Sequencing on machine
Sequencing was performed on a gene sequencer Nextseq CN with a sequencing reagent having a sequencing read length of 300 cycles (Paired-End Reads, 2X 150 cycles), suggesting a sequencing data volume of 800M per sample library. The number of sample libraries to be sequenced is not higher than 48, and NextSeq 500 Mid Output v2 Reagent kit (300 cycles) reagent is recommended for detection; the number of sample libraries to be sequenced is higher than 48 and not higher than 96, and NextSeq 500 High Output v2 Reagent kit (300 cycles) reagent is recommended for detection.
(1) Taking REAGENT CARTRIDGE, HT1 and flow cell out in advance, placing the flow cell in a room temperature balance 30min,Reagent Cartridge, placing the flow cell in a room temperature water bath for 1h, standing the HT1 at room temperature, thawing the HT1 at room temperature, and shaking and mixing the materials uniformly.
(2) Mixing all sample libraries to be sequenced according to the requirement of sequencing data, diluting the concentration of each library to 4nM by using a nucleic acid quantitative kit QubitdsDNA HS ASSAY KIT and a matched instrument, taking a new centrifuge tube with equal volume, taking each library for mixing, and keeping the total volume after mixing at least 5 mu L.
(3) Fresh 0.2N NaOH was prepared, and 1. Mu.L of 1N NaOH was added to 4. Mu.L of purified water and mixed well.
(4) Taking 5 mu L of 4 nM mixed library into a new 1.5 mL centrifuge tube, adding 5 mu L of freshly prepared 0.2N NaOH, blowing and mixing uniformly, standing for 5min at room temperature to denature the 4 nM mixed library, adding 990 mu LHT1 after denaturalization, and diluting the mixed library to 20 pM.
(5) A new 1.5 mL centrifuge tube was added to 1365. Mu.L HT1 after mixing.
(6) 135. Mu.L of the mixed library diluted to 20 pM. Mu.L was added to 1365. Mu.L of HT1 to give a total volume of 1500. Mu.L of the final on-press mixed library.
(7) Taking out REAGENT CARTRIDGE thawed in a room temperature water bath, drying by dust-free paper, turning over for 5 times, and uniformly mixing the reagents.
(8) The final on-machine mix library mixed with PhiX control was injected into well 10 using a clean 1 mL pipette tip to puncture the well 10 seal with Load Samples tag on REAGENT CARTRIDGE.
(9) And (3) carrying out reagent loading operation according to the prompt of the operation setting of the sequencer, and clicking a start button to sequence after the self-checking of the sequencer is finished, wherein the sequencing time is 26-29h.
7. HPV nucleic acid typing and integrated biological information analysis flow
(1) After sequencing was completed, BCL2fastq v2.20.0.422 software from illumina was used to convert the BCL files generated by sequencing into fastq files corresponding to the samples.
(2) And using the iltiming v0.6 software to read the record information of InterOp catalogues in the sequencing file, and carrying out quality analysis and evaluation on the sequencing. Fastp v0.20.0 for quality control, the Q30 mass value is required to be more than 80%.
(3) After the quality assessment is completed, the data is preprocessed, and the quality control is carried out on the original data according to the base and the quality of the fastq file (based on fastp v0.20.0 software).
(4) Sequence alignment: the base sequences in fastq files were aligned to human reference genome hg38 (GRCh 38) and HPV genomes to generate bam files (based on BWA v0.7.17, samtoolsv1.9 and picard v2.20.6 software: alignment).
(5) HPV type panel analysis: the numbers and proportions of reads for each HPV in the samples were analyzed by sequence alignment files using a typing detection module (based on HPVHPVKITTYPER V1.0.0 software).
(6) HPV integration analysis: using an integration detection module (based on hpvkitHPVFusionCallerv software), HPV integration sites in samples were analyzed by site comparison of sequences of HPV and human genome in alignment in sequence alignment files and annotated in conjunction with databases.
(7) And (3) result judgment: typing analysis, wherein if the single HPV type is MEAN DEPTH or more than 10, the type is judged to be positive in typing; and (3) carrying out integration analysis, wherein the HPV integration read number in the unit data volume is more than or equal to 3, and judging that the type is positive for integration.
Example 3: use effect verification of the kit
The present invention will be described in further detail with reference to the following embodiments.
1. High throughput sequencing detection of HPV genotyping integration of 20 reference samples and 16 clinical samples
Sample numbers S1-S36, wherein S1-S18 are 10-4 copies/mL of typing plasmid reference, HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82, S19 and S20 are SiHa cells (known HPV16 integration sample) and HeLa cell DNA (known HPV18 integration sample) with concentrations of 0.25 ng/. Mu.L, respectively, and S21-S36 are clinical samples. Detection result: the HPV type and the integration state corresponding to the reference sample are detected by using the method and the kit provided by the invention, so that the method and the kit can accurately and rapidly detect the actual sample, and have practical use value. The probe set and the kit for HPV typing and integration detection provided by the invention have the characteristics of simplicity and convenience in operation, high flux, good specificity, high sensitivity and the like. The results were as follows: table 7 shows the quality control results of the high-throughput sequencing of 36 samples, table 8 shows the typing results of the high-throughput sequencing of 36 samples, and Table 9 shows the integration results of the high-throughput sequencing of 18 samples.
/>
/>
/>
SEQUENCE LISTING
<110> Kadetweisi biotechnology Co., ltd
<120> A probe for detecting human papillomavirus HPV26 and kit therefor
<130> 0
<160> 14
<170> PatentIn version 3.5
<210> 1
<211> 24119
<212> DNA
<213> Artificial Sequence
<220>
<223> Probe type HPV26
<400> 1
taacaattat atgttactaa aagggtgtaa ccgaaaacgg ttgcaaccga aaccggtaca 60
tataaaagta aaaggctagc tacgtgcaaa acagctatgt ataaaagtaa aaggctagct 120
acgtgcaaaa cagctatgtt cgaggatcct agagaacgac ccagaacgct acatgagcta 180
tgtgaaagct tgaatactac ctatgttcga ggatcctaga gaacgaccca gaacgctaca 240
tgagctatgt gaaagcttga atactacttt gcaaaatttg caggtacagt gtgtatattg 300
cgctacatga gctatgtgaa agcttgaata ctactttgca aaatttgcag gtacagtgtg 360
tatattgcaa ggaaacctta caatgggctg atgtatataa ctttgcaaaa tttgcaggta 420
cagtgtgtat attgcaagga aaccttacaa tgggctgatg tatataattt tgcaatttgt 480
gacctaagag tagtatatag gcaaggaaac cttacaatgg gctgatgtat ataattttgc 540
aatttgtgac ctaagagtag tatatagaga taggagtccg tcgtatgccg taaaaagatg 600
attttgcaat ttgtgaccta agagtagtat atagagatag gagtccgtcg tatgccgtaa 660
aaagatgtgt aatattttat tcaaaaataa cagagtatag gagataggag tccgtcgtat 720
gccgtaaaaa gatgtgtaat attttattca aaaataacag agtatagacg ctatacatgt 780
tctgtgtatg gtgcaacatt gtgtaatatt ttattcaaaa ataacagagt atagacgcta 840
tacatgttct gtgtatggtg caacattaga agccttaact aaaaaaagtt tatgtaattt 900
gagtatagac gctatacatg ttctgtgtat ggtgcaacat tagaagcctt aactaaaaaa 960
agtttatgta atttgttaat aaggtgtcat agatgtcaaa gacgctatac atgttctgtg 1020
tatggtgcaa cattagaagc cttaactaaa aaaagtttat gtaatttgtt aataaggtgt 1080
catagatgtc aacgtacatt tagaagcctt aactaaaaaa agtttatgta atttgttaat 1140
aaggtgtcat agatgtcaac gtacattggg gccagaagaa aaacaaagaa ttgtggatga 1200
gttaataagg tgtcatagat gtcaacgtac attggggcca gaagaaaaac aaagaattgt 1260
ggatgaaaag cgacgatttc acgaaatagc agggcagtgg ggggccagaa gaaaaacaaa 1320
gaattgtgga tgaaaagcga cgatttcacg aaatagcagg gcagtggaaa gggttgtgta 1380
caaattgttg gagaccaagg aagcgacgat ttcacgaaat agcagggcag tggaaagggt 1440
tgtgtacaaa ttgttggaga ccaaggcgcc aaacagaaac acaagtgtaa agaacacgta 1500
ggaaagggtt gtgtacaaat tgttggagac caaggcgcca aacagaaaca caagtgtaaa 1560
gaacacgtaa tggaaacata attaatattg aagatgtaat ggcgccaaac agaaacacaa 1620
gtgtaaagaa cacgtaatgg aaacataatt aatattgaag atgtaatact agatctggtg 1680
ccgcaacccg aaattgacct tgcatggaaa cataattaat attgaagatg taatactaga 1740
tctggtgccg caacccgaaa ttgacctacg ctgctacgaa caattggact atgaacaatt 1800
ctagatctgg tgccgcaacc cgaaattgac ctacgctgct acgaacaatt ggactatgaa 1860
caatttgaca gctcagatga ggatgaaaca gataatcgta tgacagctca gatgaggatg 1920
aaacagataa tcgtagtgac cagcaggcca gacaagctgg acaagaagtg tgttacagaa 1980
ttgaagcaca atgttgtatg gcgtgaccag caggccagac aagctggaca agaagtgtgt 2040
tacagaattg aagcacaatg ttgtatgtgt aatagtatag tgcagctagc tgtgcagagc 2100
agtgtgttac agaattgaag cacaatgttg tatgtgtaat agtatagtgc agctagctgt 2160
gcagagcagt cgacagaacg ttcgagtgct ggagcagatg gtgtaatagt atagtgcagc 2220
tagctgtgca gagcagtcga cagaacgttc gagtgctgga gcagatgtta atggaagacg 2280
tgtccttggt gtgccatcag agtcgacaga acgttcgagt gctggagcag atgttaatgg 2340
aagacgtgtc cttggtgtgc catcagtgtg ctgcacagta aacctgcaat ggactgtgaa 2400
agtgtgctgc acagtaaacc tgcaatggac tgtgaaggta caaatgagga ggggcggggg 2460
tgtacagggt ggttttcagt agaagctata gtggaaaaac gaaggtacaa atgaggaggg 2520
gcgggggtgt acagggtggt tttcagtaga agctatagtg gaaaaacata caggggacac 2580
aatatcagat gatgaaacag gggtggtttt cagtagaagc tatagtggaa aaacatacag 2640
gggacacaat atcagatgat gaaacagaca atagtagtga tacagggtcg gacctaatag 2700
catacagggg acacaatatc agatgatgaa acagacaata gtagtgatac agggtcggac 2760
ctaataggat ttatagatga tagtagtata agtgattatg gacaatagta gtgatacagg 2820
gtcggaccta ataggattta tagatgatag tagtataagt gattcgtaag aacaggaggt 2880
aacccaggca ttgtttcagg ggatttatag atgatagtag tataagtgat tcgtaagaac 2940
aggaggtaac ccaggcattg tttcaggcac aacaaaaaca ggcaaataca aaggcagtgc 3000
gcagaacagg aggtaaccca ggcattgttt caggcacaac aaaaacaggc aaatacaaag 3060
gcagtgcgca atttaaaacg aaagttacta ggtagtcaga ggcacaacaa aaacaggcaa 3120
atacaaaggc agtgcgcaat ttaaaacgaa agttactagg tagtcagaac agcccgttgc 3180
aagacataac aaatcaacac cgcaatttaa aacgaaagtt actaggtagt cagaacagcc 3240
cgttgcaaga cataacaaat caacacagac agcaaagcga cagtcagcag aatacacacc 3300
aacagcccgt tgcaagacat aacaaatcaa cacagacagc aaagcgacag tcagcagaat 3360
acacaccaag taaataattc acaggccaaa aggagagccg gacagcaaag cgacagtcag 3420
cagaatacac accaagtaaa taattcacag gccaaaagga gagccgtgga cagtgtaccg 3480
gacagcgggt atggctatac caagtaaata attcacaggc caaaaggaga gccgtggaca 3540
gtgtaccgga cagcgggtat ggctatactg aagtggaaac tcttacgccc gtacaggtag 3600
ccgtggacag tgtaccggac agcgggtatg gctatactga agtggaaact cttacgcccg 3660
tacaggtaga taaacaatat gaagaaaatg gcgggttgcc actgaagtgg aaactcttac 3720
gcccgtacag gtagataaac aatatgaaga aaatggcggg ttgcctagtg tgtgtagtca 3780
gggggggtca acgtactcag gataaacaat atgaagaaaa tggcgggttg cctagtgtgt 3840
gtagtcaggg ggggtcaacg tactcagtgg aagatatcga tgtagacaca catgtaaaca 3900
gtgtgtgtag tcaggggggg tcaacgtact cagtggaaga tatcgatgta gacacacatg 3960
taaacagtgt tacacaaata tgtgaattat taaaatgtag gtggaagata tcgatgtaga 4020
cacacatgta aacagtgtta cacaaatatg tgaattatta aaatgtagta atgtaaaagc 4080
agcattgtta agtaaattta agtgttacac aaatatgtga attattaaaa tgtagtaatg 4140
taaaagcagc attgttaagt aaatttaaaa cagtatatgg tgtaagtttt gcagaactag 4200
gtaatgtaaa agcagcattg ttaagtaaat ttaaaacagt atatggtgta agttttgcag 4260
aactagtacg ggtgtttaaa agtgacaaaa ccgtatgttc aacagtatat ggtgtaagtt 4320
ttgcagaact agtacgggtg tttaaaagtg acaaaaccgt atgttcagat tgggtgtgtg 4380
cagcattcgg tgtggcaggc gtacgggtgt ttaaaagtga caaaaccgta tgttcagatt 4440
gggtgtgtgc agcattcggt gtggcaggct ctgtagcaga aagtattaaa tcattaatac 4500
tcagattggg tgtgtgcagc attcggtgtg gcaggctctg tagcagaaag tattaaatca 4560
ttaatacaac aatattgttt atattatcat atacaatgtt ggctctgtag cagaaagtat 4620
taaatcatta atacaacaat attgtttata ttatcatata caatgtttaa catgtaattg 4680
gggagtaata gtactacgta caacaatatt gtttatatta tcatatacaa tgtttaacat 4740
gtaattgggg agtaatagta ctacgtatag tgcgctttac atgtgcaaaa aacagaacaa 4800
ttaacatgta attggggagt aatagtacta cgtatagtgc gctttacatg tgcaaaaaac 4860
agaacaacaa ttaaaaactg cctatgtatg ttattaaatg gctagtgcgc tttacatgtg 4920
caaaaaacag aacaacaatt aaaaactgcc tatgtatgtt attaaatgtg ccagaaacgc 4980
aattactaat tgaaccacca acaattaaaa actgcctatg tatgttatta aatgtgccag 5040
aaacgcaatt actaattgaa ccaccaaaat tgcgaagtac agcagtagca ttatattttt 5100
gtgccagaaa cgcaattact aattgaacca ccaaaattgc gaagtacagc agtagcatta 5160
tatttttata aaacagggtt gtccaatata agtgagacat aattgaacca ccaaaattgc 5220
gaagtacagc agtagcatta tatttttata aaacagggtt gtccaatata agtgagacat 5280
atggagatac accagaatgg aattgcgaag tacagcagta gcattatatt tttataaaac 5340
agggttgtcc aatataagtg agacatatgg agatacacca gaatggatag tacgacaaac 5400
tataaaacag ggttgtccaa tataagtgag acatatggag atacaccaga atggatagta 5460
cgacaaacac aattagaaca tagttttgat gcgtatacat tatggagata caccagaatg 5520
gatagtacga caaacacaat tagaacatag ttttgatgcg tatacatttg atttatcaaa 5580
aatggtgcaa tgggcgttcg acacaattag aacatagttt tgatgcgtat acatttgatt 5640
tatcaaaaat ggtgcaatgg gcgttcgatc atgacataac agatgatagt gaaattgcat 5700
tttgatttat caaaaatggt gcaatgggcg ttcgatcatg acataacaga tgatagtgaa 5760
attgcattta aatcgtaaca gttagctgac atagatagta gatcatgaca taacagatga 5820
tagtgaaatt gcatttaaat cgtaacagtt agctgacata gatagtacgt aagctgcctt 5880
tttaaaaagc aattgtcagg aacagatgat agtgaaattg catttaaatc gtaacagtta 5940
gctgacatag atagtacgta agctgccttt ttaaaaagca attgtcaggc aaaatatgta 6000
gcatttaaat cgtaacagtt agctgacata gatagtacgt aagctgcctt tttaaaaagc 6060
aattgtcagg caaaatatgt aaaagactgt gttaaatcgt aacagttagc tgacatagat 6120
agtacgtaag ctgccttttt aaaaagcaat tgtcaggcaa aatatgtaaa agactgtgca 6180
accatgacta gagtacgtaa gctgcctttt taaaaagcaa ttgtcaggca aaatatgtaa 6240
aagactgtgc aaccatgact agacattata aaagagcaca gacgtaagct gcctttttaa 6300
aaagcaattg tcaggcaaaa tatgtaaaag actgtgcaac catgactaga cattataaaa 6360
gagcacagaa acgatctatg tgggcaaaat atgtaaaaga ctgtgcaacc atgactagac 6420
attataaaag agcacagaaa cgatctatgt gtatgtcaca atggctacaa tatagatgtt 6480
ctgacattat aaaagagcac agaaacgatc tatgtgtatg tcacaatggc tacaatatag 6540
atgttctaaa atagaagagg gcgggtcgtg gaaggaaatt gcgtgtatgt cacaatggct 6600
acaatataga tgttctaaaa tagaagaggg cgggtcgtgg aaggaaattg ccaaattttt 6660
aaggtttcaa catgtaaact ttaaaataga agagggcggg tcgtggaagg aaattgccaa 6720
atttttaagg tttcaacatg taaactttat ttatttttta caagtgttaa aacagttttt 6780
aagccaaatt tttaaggttt caacatgtaa actttattta ttttttacaa gtgttaaaac 6840
agtttttaaa gggtacccca aagcacaatt gtatagtaat attttatttt ttacaagtgt 6900
taaaacagtt tttaaagggt accccaaagc acaattgtat agtaatatat ggaccgccaa 6960
atactggtaa gtcacagttt gcaagggtac cccaaagcac aattgtatag taatatatgg 7020
accgccaaat actggtaagt cacagtttgc aatgagtttt ataaaatttc gtaaagggtc 7080
agggaccgcc aaatactggt aagtcacagt ttgcaatgag ttttataaaa tttcgtaaag 7140
ggtcagtcat ttcatatgta aattcaaata gccatttttg gcatttcgta aagggtcagt 7200
catttcatat gtaaattcaa atagccattt ttggctgcag cctttagaag cgtaaaaagt 7260
tgcagtatta gatgcgtagt catttcatat gtaaattcaa atagccattt ttggctgcag 7320
cctttagaag cgtaaaaagt tgcagtatta gatgcgtata catatagctg ctggttatgg 7380
ctgcagcctt tagaagcgta aaaagttgca gtattagatg cgtatacata tagctgctgg 7440
ttatatattg ataaatattt acgtaacttt ttagatgggt attagatgcg tatacatata 7500
gctgctggtt atatattgat aaatatttac gtaacttttt agatggaaat ccctgttgta 7560
tagacagaaa acatagaata tattgataaa tatttacgta actttttaga tggaaatccc 7620
tgttgtatag acagaaaaca tagaagccta ctgcaagtta ccgtaccccc attaataagg 7680
aaatccctgt tgtatagaca gaaaacatag aagcctactg caagttaccg tacccccatt 7740
aataattacc tcaaatataa atcctcaaga agataactag cctactgcaa gttaccgtac 7800
ccccattaat aattacctca aatataaatc ctcaagaaga taactcactt ttgtatttac 7860
atagtagagt aacagtgaat tacctcaaat ataaatcctc aagaagataa ctcacttttg 7920
tatttacata gtagagtaac agtgatacca tttccaaata catttccatt tgacagcact 7980
cacttttgta tttacatagt agagtaacag tgataccatt tccaaataca tttccatttg 8040
acagcaatgg gaatcctgta tcgtaattga ctgatgtata catagtagag taacagtgat 8100
accatttcca aatacatttc catttgacag caatgggaat cctgtatcgt aattgactga 8160
tgtaaattgg aaaataccat ttccaaatac atttccattt gacagcaatg ggaatcctgt 8220
atcgtaattg actgatgtaa attggaaaag ctttttttcc accacctggt ccagcatttc 8280
catttgacag caatgggaat cctgtatcgt aattgactga tgtaaattgg aaaagctttt 8340
tttccaccac ctggtccaga ttagatttgg aggatcgtaa ttgactgatg taaattggaa 8400
aagctttttt tccaccacct ggtccagatt agatttggag gaggacgcgg acaaagaaaa 8460
tggagaattg gaaaagcttt ttttccacca cctggtccag attagatttg gaggaggacg 8520
cggacaaaga aaatggagaa cctttgccag cgtttaacgt agtgcctttt ttccaccacc 8580
tggtccagat tagatttgga ggaggacgcg gacaaagaaa atggagaacc tttgccagcg 8640
tttaacgtag tgccaggaga aaatacagat tagatttgga ggaggacgcg gacaaagaaa 8700
atggagaacc tttgccagcg tttaacgtag tgccaggaga aaatactaga ctattatgaa 8760
ctggacagga ggacgcggac aaagaaaatg gagaaccttt gccagcgttt aacgtagtgc 8820
caggagaaaa tactagacta ttatgaactg gacagtaata aattaaatgg agaacctttg 8880
ccagcgttta acgtagtgcc aggagaaaat actagactat tatgaactgg acagtaataa 8940
attaactgat caaattgatt attggcgttt aacgtagtgc caggagaaaa tactagacta 9000
ttatgaactg gacagtaata aattaactga tcaaattgat tattggaaac tggtacgatg 9060
ccaggagaaa atactagact attatgaact ggacagtaat aaattaactg atcaaattga 9120
ttattggaaa ctggtacgat atgaatgtgc aatattttac agtaataaat taactgatca 9180
aattgattat tggaaactgg tacgatatga atgtgcaata ttttataaag ctcgtgaagg 9240
aaaccgtaaa tgtataaacg gaaactggta cgatatgaat gtgcaatatt ttataaagct 9300
cgtgaaggaa accgtaaatg tataaaccac caggtggtgc cctctactgt tgtgtgtaaa 9360
agctcgtgaa ggaaaccgta aatgtataaa ccaccaggtg gtgccctcta ctgttgtgtg 9420
taaacaaaag gcatggcagg caattgaaat acatatagcc caccaggtgg tgccctctac 9480
tgttgtgtgt aaacaaaagg catggcaggc aattgaaata catatagcat tgcagtcgtt 9540
aataaacacg gactataatc aaaaggcatg gcaggcaatt gaaatacata tagcattgca 9600
gtcgttaata aacacggact ataatacaga agcttggaca cgtagagaca caagctatga 9660
gcattgcagt cgttaataaa cacggactat aatacagaag cttggacacg tagagacaca 9720
agctatgaaa tgtatatgac agaacctaaa cattgtttta cagaagcttg gacacgtaga 9780
gacacaagct atgaaatgta tatgacagaa cctaaacatt gttttaaaaa agaaggaaca 9840
acggtaacag tggtatttgt gaaatgtata tgacagaacc taaacattgt tttaaaaaag 9900
aaggaacaac ggtaacagtg gtatttgatt gtaataagga aaatacaatg gattatatta 9960
aaagaaggaa caacggtaac agtggtattt gattgtaata aggaaaatac aatggattat 10020
attaggtgga aatatgtgta ttataaaact gatataggga ggtggaaata tgtgtattat 10080
aaaactgata tagggtggtg taaaggtact ggagatgttg cgtaaaaagg gatatattat 10140
acacaagggg catataagca gggtggtgta aaggtactgg agatgttgcg taaaaaggga 10200
tatattatac acaaggggca tataagcagt attacgtgga ctttaaacaa gaggcggaag 10260
caaaagggat atattataca caaggggcat ataagcagta ttacgtggac tttaaacaag 10320
aggcggaaaa atatgggaca ggtgtgcaat gggctgtacg cagtattacg tggactttaa 10380
acaagaggcg gaaaaatatg ggacaggtgt gcaatgggct gtacatgtgt gtggtcaggt 10440
aatctgttgt cctgaattta aaatatggga caggtgtgca atgggctgta catgtgtgtg 10500
gtcaggtaat ctgttgtcct gaatttgtat ctagtacctg cagcagcaac caaatatcct 10560
gtgtgtggtc aggtaatctg ttgtcctgaa tttgtatcta gtacctgcag cagcaaccaa 10620
atatccactg ctaaaactgc tgagccagta tcaaacgcct tgtatctagt acctgcagca 10680
gcaaccaaat atccactgct aaaactgctg agccagtatc aaacgccacc acccagacca 10740
ccgaagccta cgtgcccgta ctgctaaaac tgctgagcca gtatcaaacg ccaccaccca 10800
gaccaccgaa gcctacgtgc ccgtgggcac caaggaaacc gaggcgccat acccaggaac 10860
accacccaga ccaccgaagc ctacgtgccc gtgggcacca aggaaaccga ggcgccatac 10920
ccaggaaagc gacgacgact cagtggacct gacaccacct gggcaccaag gaaaccgagg 10980
cgccataccc aggaaagcga cgacgactca gtggacctga caccaccgtc accacagtca 11040
ccactgtcac cacagctgca aagcgacgac gactcagtgg acctgacacc accgtcacca 11100
cagtcaccac tgtcaccaca gctgccacac agcccggaca gtcagtggac tatacaaacc 11160
gtcaccacag tcaccactgt caccacagct gccacacagc ccggacagtc agtggactat 11220
acaaacaaca acctacacag tacaagtgga ggccatcaca cacagcccgg acagtcagtg 11280
gactatacaa acaacaacct acacagtaca agtggaggcc atcacccggg aagggacacg 11340
agtagtgacc aaactgtgtc aacaacctac acagtacaag tggaggccat cacccgggaa 11400
gggacacgag tagtgaccaa actgtgttta tagtacacct aaaaggtgat acaaatagtc 11460
ccgggaaggg acacgagtag tgaccaaact gtgtttatag tacacctaaa aggtgataca 11520
aatagtttaa aatgtttaag atatagattt aaaaagcatg tttatagtac acctaaaagg 11580
tgatacaaat agtttaaaat gtttaagata tagatttaaa aagcataaag gattgtattg 11640
caatgtatca tctacctgga caaatagttt aaaatgttta agatatagat ttaaaaagca 11700
taaaggattg tattgcaatg tatcatctac ctggcattgg accagtaatt ttaaaatgtt 11760
taagatatag atttaaaaag cataaaggat tgtattgcaa tgtatcatct acctggcatt 11820
ggaccagtaa tgataccaat caacaaggca aggattgtat tgcaatgtat catctacctg 11880
gcattggacc agtaatgata ccaatcaaca aggcattgta acaattacct ttaacagtat 11940
aacacaacgg cattgtaaca attaccttta acagtataac acaacgtaat aattttttaa 12000
caactgttaa aataccacaa agtataactt caacattggg aataatgtcc gtaataattt 12060
tttaacaact gttaaaatac cacaaagtat aacttcaaca ttgggaataa tgtcattgta 12120
atatagtgta tattttacca acacacaagc aaagtataac ttcaacattg ggaataatgt 12180
cattgtaata tagtgtatat tttaccaaca cacaagccaa tatgtgctgc taacacacct 12240
atatacctgc attgtaatat agtgtatatt ttaccaacac acaagccaat atgtgctgct 12300
aacacaccta tatacctgta atcattattc cttttatagt ttatgtgtta gccaatatgt 12360
gctgctaaca cacctatata cctgtaatca ttattccttt tatagtttat gtgtttgtgc 12420
tttgcgtgtg tgtgtgtgtg ttgctgtgtt gtaatcatta ttccttttat agtttatgtg 12480
tttgtgcttt gcgtgtgtgt gtgtgtgttg ctgtgttgtt tgttgccact tttgctttcc 12540
atttatgtgt gtgctttgcg tgtgtgtgtg tgtgttgctg tgttgtttgt tgccactttt 12600
gctttccatt tatgtgtttg cagcctcgct attattagtg ttttgttttt tgtttgttgc 12660
cacttttgct ttccatttat gtgtttgcag cctcgctatt attagtgttt tgtttttggt 12720
ttgtggtatc tacatcatat ataactaccg tttgcagcct cgctattatt agtgttttgt 12780
ttttggtttg tggtatctac atcatatata actacctata ttgtgtatat ttgcttattt 12840
tttatacctt tggtttgtgg tatctacatc atatataact acctatattg tgtatatttg 12900
cttatttttt atacctgctt gttttttaca tttttatact gtaatggtac tatattgtgt 12960
atatttgctt attttttata cctgcttgtt ttttacattt ttatactgta atggtaattg 13020
ctacttagtc cctttaataa acgtgttact gcttgttttt tacattttta tactgtaatg 13080
gtaattgcta cttagtccct ttaataaacg tgttacaatg gtagctgtcc gtgcccctcg 13140
acgcaaacgg ctacttagtc cctttaataa acgtgttaca atggtagctg tccgtgcccc 13200
tcgacgcaaa cgagcatcag ctacagactt atacaaaaca tgtaaggccc gagcatcagc 13260
tacagactta tacaaaacat gtaaggccgc tggtacgtgc cctcctgatg ttattcctaa 13320
aattgaaggt tctacccttg ctgataagaa ggccgctggt acgtgccctc ctgatgttat 13380
tcctaaaatt gaaggttcta cccttgctga taagatatta caatggagtg gtttgggaat 13440
atttttaggc taaaattgaa ggttctaccc ttgctgataa gatattacaa tggagtggtt 13500
tgggaatatt tttaggtggt cttggtatag gtacaggaac tgggtctggt attacaatgg 13560
agtggtttgg gaatattttt aggtggtctt ggtataggta caggaactgg gtctggtggg 13620
cgtactggat acattcccct aggagggggg tggtcttggt ataggtacag gaactgggtc 13680
tggtgggcgt actggataca ttcccctagg agggggtggt agaccctctg ttgtggatat 13740
cggccctact gggcgtactg gatacattcc cctaggaggg ggtggtagac cctctgttgt 13800
ggatatcggc cctacccgtc cgcccattat tattgaacct gtgggtcctg tggtagaccc 13860
tctgttgtgg atatcggccc tacccgtccg cccattatta ttgaacctgt gggtcctaca 13920
gaaccttcta tagttacttt ggtggaggac ccgtccgccc attattattg aacctgtggg 13980
tcctacagaa ccttctatag ttactttggt ggaggaatct agtattatac aatctggagc 14040
ccctataccc tacagaacct tctatagtta ctttggtgga ggaatctagt attatacaat 14100
ctggagcccc tatacctaca tttagtggtg gcaatggctt tgaacttacg aatctagtat 14160
tatacaatct ggagccccta tacctacatt tagtggtggc aatggctttg aacttaccac 14220
atcctctgca acaacacctg ctgtgttggc tacatttagt ggtggcaatg gctttgaact 14280
taccacatcc tctgcaacaa cacctgctgt gttggacatc accccctctg ctggtactgt 14340
acatgtaacc cacatcctct gcaacaacac ctgctgtgtt ggacatcacc ccctctgctg 14400
gtactgtaca tgtaacaagt accaatatac aaaatccatt atatattgaa catcaccccc 14460
tctgctggta ctgtacatgt aacaagtacc aatatacaaa atccattata tattgaaccc 14520
cctatagata taccacaggc cggggaagcc aagtaccaat atacaaaatc cattatatat 14580
tgaaccccct atagatatac cacaggccgg ggaagcatca ggtcatatat ttactacaac 14640
gtccacagcg aaccccctat agatatacca caggccgggg aagcatcagg tcatatattt 14700
actacaacgt ccacagctgg cacacatagt tatgaagaaa ttccaatggg catcaggtca 14760
tatatttact acaacgtcca cagctggcac acatagttat gaagaaattc caatggaagt 14820
atttgcttct actaatggaa caggattagg ctggcacaca tagttatgaa gaaattccaa 14880
tggaagtatt tgcttctact aatggaacag gattagaacc tattagtagt acacctattc 14940
ctggtataca gtatttgctt ctactaatgg aacaggatta gaacctatta gtagtacacc 15000
tattcctggt atacaacgag tgtcagctcc tcgtttgtat agtaaggccg aacctattag 15060
tagtacacct attcctggta tacaacgagt gtcagctcct cgtttgtata gtaaggccta 15120
tcaacaggta aaggttacag atcccaattc aacgagtgtc agctcctcgt ttgtatagta 15180
aggcctatca acaggtaaag gttacagatc ccaattttat tggtaatccc tccacatttg 15240
ttacctttgg cctatcaaca ggtaaaggtt acagatccca attttattgg taatccctcc 15300
acatttgtta cctttgataa tcctgcatat gaacctatag atgaaacacg gtaatccctc 15360
cacatttgtt acctttgata atcctgcata tgaacctata gatgaaacac ttacatcgta 15420
ttccagtagt actgtagcac ctgaccccgt acatcgtatt ccagtagtac tgtagcacct 15480
gaccccgatt ttttggacat tattgcattg catcgtccgg cccttacatc tcgcaaaggt 15540
actgtacgcg accccgattt tttggacatt attgcattgc atcgtccggc ccttacatct 15600
cgcaaaggta ctgtacgcta tagtaggttg ggtcaaaagg ccactatgac gtccggccct 15660
tacatctcgc aaaggtactg tacgctatag taggttgggt caaaaggcca ctatgaaaac 15720
acgtagtgga aaacaaattg gagctacagg ctatagtagg ttgggtcaaa aggccactat 15780
gaaaacacgt agtggaaaac aaattggagc tacagtacat tattatcatg atattagtcc 15840
tatacagtca aacacgtagt ggaaaacaaa ttggagctac agtacattat tatcatgata 15900
ttagtcctat acagtctttt gctgaacacg aagaaattga attgcagccg tacattatta 15960
tcatgatatt agtcctatac agtcttttgc tgaacacgaa gaaattgaat tgcagccttt 16020
acatacatct acccattcat ctgcaccttc ttttgctgaa cacgaagaaa ttgaattgca 16080
gcctttacat acatctaccc attcatctgc acctttgttt gatatatcgt aagaccctga 16140
tacagttccc tttacataca tctacccatt catctgcacc tttgtttgat atatcgtaag 16200
accctgatac agttcctagc atacatacgc cgcgcatgtc atattcccct gtttgatata 16260
tcgtaagacc ctgatacagt tcctagcata catacgccgc gcatgtcata ttcccctaca 16320
acattaccag ttccaagatc gtactccaac ctagcataca tacgccgcgc atgtcatatt 16380
cccctacaac attaccagtt ccaagatcgt actccaatgt gttttcctct attaatactt 16440
ccactaccac ctacaacatt accagttcca agatcgtact ccaatgtgtt ttcctctatt 16500
aatacttcca ctaccaatgt tactgtgcct ttatccacct catttgaact gtgttttcct 16560
ctattaatac ttccactacc aatgttactg tgcctttatc cacctcattt gaactacctg 16620
tatatagtgg gtcagacatt tacacgcccg ttactgtgcc tttatccacc tcatttgaac 16680
tacctgtata tagtgggtca gacatttaca cgcccacatc ttccccgaca tggccatcat 16740
tgccccccct acctgtatat agtgggtcag acatttacac gcccacatct tccccgacat 16800
ggccatcatt gcccccccca cccaccacta acttacctgc aatagttgtg cccacatctt 16860
ccccgacatg gccatcattg ccccccccac ccaccactaa cttacctgca atagttgtgc 16920
atggggataa ttattattta tggccctatc cccacccacc actaacttac ctgcaatagt 16980
tgtgcatggg gataattatt atttatggcc ctatatttat ttaatccata aacgccgtaa 17040
acgtcgtacg catggggata attattattt atggccctat atttatttaa tccataaacg 17100
ccgtaaacgt cgtacttatt ttttttcaga tggctttgtg gcgtactagt attatttatg 17160
gccctatatt tatttaatcc ataaacgccg taaacgtcgt acttattttt tttcagatgg 17220
ctttgtggcg tactagtgac agtttattta atccataaac gccgtaaacg tcgtacttat 17280
tttttttcag atggctttgt ggcgtactag tgacagcaag gtatatcttc ctcccacccc 17340
tggccttatt ttttttcaga tggctttgtg gcgtactagt gacagcaagg tatatcttcc 17400
tcccacccct gtgtctcggg ttgtcaacac ggatgaatat gttttttcag atggctttgt 17460
ggcgtactag tgacagcaag gtatatcttc ctcccacccc tgtgtctcgg gttgtcaaca 17520
cggatgaata tgtgtgacag caaggtatat cttcctccca cccctgtgtc tcgggttgtc 17580
aacacggatg aatatgtaac tcgcaccggc atatattatt cgtagggcag ctcgtgtctc 17640
gggttgtcaa cacggatgaa tatgtaactc gcaccggcat atattattcg tagggcagct 17700
ctcgtttatt aacattagga catccatatt tttctcgcac cggcatatat tattcgtagg 17760
gcagctctcg tttattaaca ttaggacatc catatttttc catacctaaa actggccaaa 17820
aggccgaaat tcctccatac ctaaaactgg ccaaaaggcc gaaattccta aggtatctgc 17880
ctatcagtac agggtattta gagtgcacct acctgatcct aataaatttg gatcctaagg 17940
tatctgccta tcagtacagg gtatttagag tgcacctacc tgatcctaat aaatttggat 18000
tgcctgatcc acagttatat aatcctgaca cagagagtgc acctacctga tcctaataaa 18060
tttggattgc ctgatccaca gttatataat cctgacacag aacgcctggt gtgggcctgt 18120
gttggtgttg aagtgcctga tccacagtta tataatcctg acacagaacg cctggtgtgg 18180
gcctgtgttg gtgttgaagt tggtagagga cagccattag gcattggcct taggaacgcc 18240
tggtgtgggc ctgtgttggt gttgaagttg gtagaggaca gccattaggc attggcctta 18300
gtggacatcc tttgtttaat aagttggatg atagttggta gaggacagcc attaggcatt 18360
ggccttagtg gacatccttt gtttaataag ttggatgata ccgaaaactc tcatttggct 18420
actgtaacgt aagagtggac atcctttgtt taataagttg gatgataccg aaaactctca 18480
tttggctact gtaacgtaag acactgacaa cagggacaat gtttcagttg ataccgaaaa 18540
ctctcatttg gctactgtaa cgtaagacac tgacaacagg gacaatgttt cagttgataa 18600
taaacaaaca cagttatgta ttataggttg tacgacactg acaacaggga caatgtttca 18660
gttgataata aacaaacaca gttatgtatt ataggttgta caccgccctt gggagagcac 18720
tggggtattg gcaaataaac aaacacagtt atgtattata ggttgtacac cgcccttggg 18780
agagcactgg ggtattggca ctatatgtaa aaatacacag acacaacgtg gggacaccgc 18840
ccttgggaga gcactggggt attggcacta tatgtaaaaa tacacagaca caacgtgggg 18900
attgcccccc cttagaatta atttccagca ttactatatg taaaaataca cagacacaac 18960
gtggggattg ccccccctta gaattaattt ccagcattat tgaggatggc gatatgattg 19020
atacaggctt tggggattgc ccccccttag aattaatttc cagcattatt gaggatggcg 19080
atatgattga tacaggcttt ggagctatgg attttactgc cttacaggct accttgagga 19140
tggcgatatg attgatacag gctttggagc tatggatttt actgccttac aggctaccaa 19200
atcagatgtg cccattgata ttagtcaatc caccaggctt tggagctatg gattttactg 19260
ccttacaggc taccaaatca gatgtgccca ttgatattag tcaatccaca tgtaaatatc 19320
ctgattatct taaggagcta tggattttac tgccttacag gctaccaaat cagatgtgcc 19380
cattgatatt agtcaatcca catgtaaata tcctgattat cttaaaatgt ctgaccaaat 19440
cagatgtgcc cattgatatt agtcaatcca catgtaaata tcctgattat cttaaaatgt 19500
ctgcagatac atatggaaac agcatgttta aatcagatgt gcccattgat attagtcaat 19560
ccacatgtaa atatcctgat tatcttaaaa tgtctgcaga tacatatgga aacagcatgt 19620
ttttttttcc cacatgtaaa tatcctgatt atcttaaaat gtctgcagat acatatggaa 19680
acagcatgtt tttttttctt cgccgggaac aattatttgc cagacatttg cagatacata 19740
tggaaacagc atgttttttt ttcttcgccg ggaacaatta tttgccagac atttttataa 19800
taaggcgggg gctgttgggg cgtatatacc ttcgccggga acaattattt gccagacatt 19860
tttataataa ggcgggggct gttggggcgt atatacccac cactttgtat attaaaggtg 19920
ctgaatcaga taataaggcg ggggctgttg gggcgtatat acccaccact ttgtatatta 19980
aaggtgctga atcaggcagg gagcccccta catcttctat ttattctgcc ccaccacttt 20040
gtatattaaa ggtgctgaat caggcaggga gccccctaca tcttctattt attctgctac 20100
acctagtggc tctatggtta cttcggatgg gcagggagcc ccctacatct tctatttatt 20160
ctgctacacc tagtggctct atggttactt cggcgtaaca actatttaat aagccatact 20220
ggttacaacg ctacacctag tggctctatg gttacttcgg cgtaacaact atttaataag 20280
ccatactggt tacaacgtgc acagggtcat aataatggta tctgttgggg gttacttcgg 20340
cgtaacaact atttaataag ccatactggt tacaacgtgc acagggtcat aataatggta 20400
tctgttgggg caatcaattg tttgttacgc acaactattt aataagccat actggttaca 20460
acgtgcacag ggtcataata atggtatctg ttggggcaat caattgtttg ttacctgtgt 20520
tgataccacg tgcacagggt cataataatg gtatctgttg gggcaatcaa ttgtttgtta 20580
cctgtgttga taccacccgc agtactaacc ttaccattag tacattatgg ggcaatcaat 20640
tgtttgttac ctgtgttgat accacccgca gtactaacct taccattagt acattatctg 20700
cagcatctgc atccactcca tttaaaccac ccgcagtact aaccttacca ttagtacatt 20760
atctgcagca tctgcatcca ctccatttaa accatctgat tataaacaat ttataagaca 20820
tggcgaagtc tgcagcatct gcatccactc catttaaacc atctgattat aaacaattta 20880
taagacatgg cgaagaatat gaattacaat ttatatttca gttgtgtatc tgattataaa 20940
caatttataa gacatggcga agaatatgaa ttacaattta tatttcagtt gtgtaaaata 21000
acacttacaa cagatgttat ggcttacaga atatgaatta caatttatat ttcagttgtg 21060
taaaataaca cttacaacag atgttatggc ttacatacat ttaatgacgt actccatatt 21120
ggaggattta tttcagttgt gtaaaataac acttacaaca gatgttatgg cttacataca 21180
tttaatgacg tactccatat tggaggattg gaattttgga aataacactt acaacagatg 21240
ttatggctta catacattta atgacgtact ccatattgga ggattggaat tttggactaa 21300
ccttacctcc cactgctagt acatttaatg acgtactcca tattggagga ttggaatttt 21360
ggactaacct tacctcccac tgctagtttg gaagcgtact ataggtttat taaaaactct 21420
ggaattttgg actaacctta cctcccactg ctagtttgga agcgtactat aggtttatta 21480
aaaactctgc tactacctgt cagcgtaacg cccctcctga gtttggaagc gtactatagg 21540
tttattaaaa actctgctac tacctgtcag cgtaacgccc ctcctgtgcc aaaggaagat 21600
ccttttcaaa aatttaaatc tctgctacta cctgtcagcg taacgcccct cctgtgccaa 21660
aggaagatcc ttttcaaaaa tttaaatttt gggatgtaga tttaaaagaa aaattttctg 21720
tgccaaagga agatcctttt caaaaattta aattttggga tgtagattta aaagaaaaat 21780
tttctattga tttggatcaa tttccactag ggcgtaagtt tttgggatgt agatttaaaa 21840
gaaaaatttt ctattgattt ggatcaattt ccactagggc gtaagtttat gttacaggcc 21900
ggcatacaac ggcggccgat tgatttggat caatttccac tagggcgtaa gtttatgtta 21960
caggccggca tacaacggcg gccgaaacta ggcaccaaac gtcccttatc ttctacctcg 22020
tttatgttac aggccggcat acaacggcgg ccgaaactag gcaccaaacg tcccttatct 22080
tctacctctt cctctaccaa acgcaaaaaa cgtaaacttc ctcttcctct accaaacgca 22140
aaaaacgtaa acttactaaa taattccgca tgtttgtgtg tgtgtatatg tttgtggtat 22200
gttatgtaag gtgtgtttga ctaaataatt ccgcatgttt gtgtgtgtgt atatgtttgt 22260
ggtatgttat gtaaggtgtg tttgtatgtg tgtacaactg tatgtaatgt aaaggcgtga 22320
tgtttgtggt atgttatgta aggtgtgttt gtatgtgtgt acaactgtat gtaatgtaaa 22380
ggcgtgtttt gtatgtatgt attatatgtc gtaatggtta tgtgtgtaca actgtatgta 22440
atgtaaaggc gtgttttgta tgtatgtatt atatgtcgta atggttatgt gttttcctgt 22500
ttgtcgtaat acttgttatg ttttgtatgt atgtattata tgtcgtaatg gttatgtgtt 22560
ttcctgtttg tcgtaatact tgttatttaa taaagtatga atgtgtcttc cgtaatggtt 22620
atgtgttttc ctgtttgtcg taatacttgt tatttaataa agtatgaatg tgtcttccgt 22680
aatggttaca tgtctttact acactatttg tcatttgttt taataaagta tgaatgtgtc 22740
ttccgtaatg gttacatgtc tttactacac tatttgtcat ttgttttacc cctgaggtaa 22800
tgggaggaac cttaggtggt ttacccctga ggtaatggga ggaaccttag gtggtgtccc 22860
ttataattat tatattacac aagtttacct tttatatgta tttcactaaa cttttgtagg 22920
gtgtccctta taattattat attacacaag tttacctttt atatgtattt cactaaactt 22980
ttgtagtgtt atatttttac tttttatatt ttctattact accttttata tgtatttcac 23040
taaacttttg tagtgttata tttttacttt ttatattttc tattactatc tattgtccca 23100
accgttttcg gtcgttcctg tgttatattt ttacttttta tattttctat tactatctat 23160
tgtcccaacc gttttcggtc gttccttatt ttagttttta tccaactttc cgtatgtatc 23220
tatctattgt cccaaccgtt ttcggtcgtt ccttatttta gtttttatcc aactttccgt 23280
atgtatcctg caggaacagt taatcctttg gcagacaact tttagttttt atccaacttt 23340
ccgtatgtat cctgcaggaa cagttaatcc tttggcagac aacacatcct gcctcctacg 23400
cttggcttgc cattttggcc acatcctgcc tcctacgctt ggcttgccat tttggcacta 23460
taagtggcgc gcctgtatta gtcacatata tttaaacaat acttacataa gcactttttt 23520
ggcactataa gtggcgcgcc tgtattagtc acatatattt aaacaatact tacataagca 23580
ctttttctta cattataata aaactgctgt taggcacata tatatttaaa caatacttac 23640
ataagcactt tttcttacat tataataaaa ctgctgttag gcacatattt ttattttatt 23700
ttataggtct tttaagtgct cttacattat aataaaactg ctgttaggca catattttta 23760
ttttatttta taggtctttt aagtgcatag ttggctaaca tatacacttt tgtttgccat 23820
atttttattt tattttatag gtcttttaag tgcatagttg gctaacatat acacttttgt 23880
ttgccaacta tgtgtctgac acatactgtt gtaacccatg catagttggc taacatatac 23940
acttttgttt gccaactatg tgtctgacac atactgttgt aacccatagt taaacacagg 24000
tgtgtatgta accgaaatgg ccaactatgt gtctgacaca tactgttgta acccatagtt 24060
aaacacaggt gtgtatgtaa ccgaaatgtg ttttgttacg tacgtaaagt ttctttata 24119
<210> 2
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 2
caagcagaag acggcatacg agattgcatg acgtgactgg agttcagacg tgt 53
<210> 3
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 3
caagcagaag acggcatacg agattgctat cggtgactgg agttcagacg tgt 53
<210> 4
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 4
caagcagaag acggcatacg agatcacaag cagtgactgg agttcagacg tgt 53
<210> 5
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 5
caagcagaag acggcatacg agattcgctg atgtgactgg agttcagacg tgt 53
<210> 6
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 6
caagcagaag acggcatacg agatcgcttt gtgtgactgg agttcagacg tgt 53
<210> 7
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 7
caagcagaag acggcatacg agatccgatg aagtgactgg agttcagacg tgt 53
<210> 8
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 8
caagcagaag acggcatacg agattgacca cagtgactgg agttcagacg tgt 53
<210> 9
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 9
caagcagaag acggcatacg agatgaagcc atgtgactgg agttcagacg tgt 53
<210> 10
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 10
caagcagaag acggcatacg agatttctgg tggtgactgg agttcagacg tgt 53
<210> 11
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 11
caagcagaag acggcatacg agatccgaaa acgtgactgg agttcagacg tgt 53
<210> 12
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 12
caagcagaag acggcatacg agatcgaaaa gggtgactgg agttcagacg tgt 53
<210> 13
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer
<400> 13
caagcagaag acggcatacg agataaccag ctgtgactgg agttcagacg tgt 53
<210> 14
<211> 60
<212> DNA
<213> Artificial Sequence
<220>
<223> Joint
<400> 14
ctacaataat tcatgtataa aactaagggc tagtataaaa gcagacattt tcgtaaccaa 60

Claims (3)

1. A kit for detecting human papillomavirus HPV26 comprising the probe: SEQ ID NO.1; the length interval of the probe is 80-150bp; the number of probe layers is 3 and a shingled design is required.
2. A method for using the kit for detecting human papillomavirus HPV26 of claim 1, for non-diagnostic and non-therapeutic purposes, comprising the steps of:
(1) Extracting sample DNA, fragmenting, constructing DNA library,
(2) Hybridization of the constructed library with the probe according to claim 1, targeted capture and quantification of the target region,
(3) High throughput sequencing, high throughput sequencing of the sample,
(4) Bioinformatic analysis of gene sequences.
3. The kit of claim 1 for non-diagnostic non-therapeutic human papillomavirus HPV detection.
CN202011260516.1A 2020-11-12 2020-11-12 Probe for detecting human papilloma virus HPV26 and kit thereof Active CN112195286B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011260516.1A CN112195286B (en) 2020-11-12 2020-11-12 Probe for detecting human papilloma virus HPV26 and kit thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011260516.1A CN112195286B (en) 2020-11-12 2020-11-12 Probe for detecting human papilloma virus HPV26 and kit thereof

Publications (2)

Publication Number Publication Date
CN112195286A CN112195286A (en) 2021-01-08
CN112195286B true CN112195286B (en) 2024-04-19

Family

ID=74034221

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011260516.1A Active CN112195286B (en) 2020-11-12 2020-11-12 Probe for detecting human papilloma virus HPV26 and kit thereof

Country Status (1)

Country Link
CN (1) CN112195286B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450885A (en) * 2014-10-29 2015-03-25 百世诺(北京)医疗科技有限公司 Kit for detecting neurofibromatosis 1 (NF1)-related gene mutation
CN107739761A (en) * 2016-08-12 2018-02-27 嘉兴允英医学检验有限公司 It is a kind of to be used for HPV partings and the high-flux sequence detection method of integration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9809864B2 (en) * 2013-03-01 2017-11-07 The Johns Hopkins University Dual sequence-capture method for quantifying trans renal HPV DNA in urine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450885A (en) * 2014-10-29 2015-03-25 百世诺(北京)医疗科技有限公司 Kit for detecting neurofibromatosis 1 (NF1)-related gene mutation
CN107739761A (en) * 2016-08-12 2018-02-27 嘉兴允英医学检验有限公司 It is a kind of to be used for HPV partings and the high-flux sequence detection method of integration

Also Published As

Publication number Publication date
CN112195286A (en) 2021-01-08

Similar Documents

Publication Publication Date Title
CN111057798A (en) LAMP primer combination and kit for detecting novel coronavirus
WO2022100444A1 (en) Probe set for human papillomavirus (hpv) typing and integration detection and kit thereof
CN111560478B (en) Kit for detecting novel coronavirus by combining reverse transcription PCR with Sanger sequencing in one-step method
CN113025701B (en) Early screening method and kit for non-alcoholic fatty liver disease susceptibility gene
CN108192965B (en) Method for detecting heterogeneity of mitochondrial genome A3243G locus
WO2022100441A1 (en) Probe set for detecting human papillomaviruses hpv16 and hpv18, and kit thereof
CN112575123B (en) Primer combination, probe combination and human papillomavirus nucleic acid detection kit
CN104928399A (en) Primer group, kit and use thereof in HPV whole-genome detection
EP1546413B1 (en) Method and kit for quantitative and qualitative determination of human papillomavirus
CN112195286B (en) Probe for detecting human papilloma virus HPV26 and kit thereof
KR101761701B1 (en) HPV Specific Probe and DNA Chip for Detecting Genetic Type of HPV Containing Thereof
CN113584225B (en) Primer and probe combination for detecting HPV (human papillomavirus) virus, typing detection reagent and application thereof
Lei et al. Development of a multiplex PCR method for detecting and typing human papillomaviruses in verrucae vulgaris
CN112195280B (en) Probe for detecting human papilloma virus HPV39 and kit thereof
CN114214416A (en) Biomarker associated with cervical cancer pre-lesion occurrence and application thereof
CN112301166A (en) Probe for detecting human papilloma virus HPV51 and kit thereof
CN112195281A (en) Probe for detecting human papilloma virus HPV56 and kit thereof
CN112266981A (en) Probe for detecting human papilloma virus HPV68 and kit thereof
CN112301165A (en) Probe for detecting human papilloma virus HPV82 and kit thereof
CN112266982A (en) Probe for detecting human papilloma virus HPV45 and kit thereof
CN112195283A (en) Probe for detecting human papilloma virus HPV31 and kit thereof
CN112522439B (en) Probe set for detecting HPV (human papilloma Virus) typing and integration of 5 human papilloma viruses and kit thereof
CN112195282A (en) Probe for detecting human papilloma virus HPV35 and kit thereof
CN112195284A (en) Probe for detecting human papilloma virus HPV73 and kit thereof
CN112301164A (en) Probe for detecting human papilloma virus HPV66 and kit thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant